No definition available.
Benign neoplasm: Pelvic bones, sacrum and coccyx
CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
177 |
4. Check minimum number of eventsNone |
177 |
5. Include endpointsNone |
177 |
6. Filter based on genotype QC (FinnGen only) |
160 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D16
- Name in latin
- Neoplasma benignum ossis coxae, ossis sacri sive ossis coccygis
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Pelvic bones, sacrum and coccyx
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of bone and articular cartilage
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 995 | 538 | 448 |
| Only index persons | 868 | 483 | 385 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.01 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.02 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 40.90 | 43.81 | 37.09 |
| Only index persons | 39.57 | 42.49 | 35.90 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 160 | 100 | 60 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.03 |
| Median age at first event (years) | 46.51 | 44.72 | 49.48 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 165
- Matched controls
- 1650
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D16.8
ICD-10 Finland
Benign neoplasm: Pelvic bones, sacrum and coccyx
+∞
171.0
133
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
70.7
30.5
34
6
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
58.1
25.2
29
6
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
+∞
20.2
19
*
21305
ICD-8 Finland
Benign neoplasm of bone and cartilage, Pelvis, sacri, coccygis
+∞
20.2
19
*
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
71.0
17.1
19
*
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.8
16.8
35
73
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
20.3
15.7
23
13
2136A
ICD-9 Finland
Benign neoplasm of bone and articular cartilage, Pelvic bones, sacrum and coccyx
+∞
14.8
14
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
11.0
12.7
24
25
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
9.7
10.1
20
23
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
39.0
9.1
11
*
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
+∞
8.4
8
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
23.4
8.1
11
5
9102
FHL
Trepanation or removal of the local bone process
47.3
7.8
9
*
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
47.3
7.8
9
*
NER50
NOMESCO Finland
Other operation for tumour of pelvis
+∞
7.3
7
*
9101
FHL
Bone biopsy
+∞
7.3
7
*
D16.90
ICD-10 Finland
Bone and articular cartilage, unspecified
+∞
6.3
6
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.1
6.3
28
101
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
6.1
73
427
B01AB05
ATC
enoxaparin; parenteral
2.3
6.1
60
324
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
20
58
3.79
6.23
1.4
1.5
—
—
—
0
0
117
853
2.28
5.45
8.4
10.1
3.88
4.10
e9/l
0.68
106
732
108
770
2.17
5.21
4.8
3.8
0.00
0.00
estimate
-0.00
14
153
99
685
2.11
5.14
6.8
7.0
1.22
1.21
mmol/l
0.03
87
597
106
762
2.09
4.86
4.9
3.8
0.00
9.72
estimate
0.50
16
167
105
755
2.07
4.77
4.9
3.7
0.00
0.00
estimate
-0.00
16
164
85
574
1.99
4.53
4.9
3.6
0.00
0.00
estimate
-0.00
14
137
31
149
2.33
3.95
1.8
2.0
417.71
390.35
nmol/l
0.33
31
141
57
353
1.94
3.76
1.8
2.1
2.82
2.76
mg/l
0.10
47
307
8
12
6.94
3.72
1.3
1.0
—
—
—
0
0
8
12
6.94
3.72
1.3
1.0
—
—
—
0
0
24
106
2.48
3.66
2.2
3.3
60.91
67.25
ml/min/173m2
0.36
14
48
131
1071
2.08
3.61
5.1
4.2
8.37
10.52
mm/h
2.18
125
998
55
341
1.92
3.59
2.6
2.6
300.50
339.45
umol/l
1.92
50
302
62
405
1.85
3.43
5.8
3.8
0.00
0.00
estimate
-0.00
15
156
29
145
2.21
3.36
9.7
7.6
—
—
—
0
0
12
35
3.61
3.18
1.2
1.4
—
—
—
0
0
133
1119
1.97
3.01
4.6
4.4
15.05
14.76
pmol/l
0.85
127
1025
65
445
1.76
3.01
3.0
2.6
56.29
67.54
u/l
0.54
59
412
21
96
2.36
2.98
2.1
1.4
—
—
—
0
0
74
527
1.73
2.97
4.1
3.6
18.03
29.10
ng/l
1.45
52
345
56
369
1.78
2.94
2.8
3.3
583.68
1246.19
ng/l
1.90
46
309
39
230
1.91
2.90
2.0
1.9
—
—
—
0
0
5
6
8.54
2.76
1.0
1.0
1768.00
1434.17
miu/ml
—
5
6
129
1086
1.86
2.76
10.0
8.1
74.71
78.20
u/l
0.56
124
1029
98
769
1.68
2.65
7.0
6.5
9.68
10.91
umol/l
1.25
93
732
89
682
1.66
2.63
3.1
2.7
—
—
estimate
—
0
0
50
332
1.73
2.51
6.1
3.8
1.02
1.02
kg/l
0.14
36
217
148
1328
2.11
2.28
6.0
5.4
1.75
1.88
mu/l
0.95
143
1236
90
712
1.58
2.20
3.4
3.0
155.19
104.96
ug/l
0.73
85
671
49
336
1.65
2.15
1.7
1.8
2.75
1.09
mg/l
0.42
38
262
5
10
5.12
2.08
1.2
1.4
—
—
—
0
0
7
20
3.61
2.08
1.0
1.1
—
—
—
0
0
11
44
2.61
2.06
1.5
1.4
296.80
328.39
ug/g
—
5
27
21
114
1.96
1.98
1.6
1.4
—
—
—
0
0
10
39
2.66
1.98
1.7
1.2
—
—
—
0
0
5
11
4.65
1.95
1.8
1.3
—
—
—
0
0
60
444
1.55
1.90
3.0
3.1
0.00
0.00
estimate
-0.00
14
131
28
170
1.78
1.89
1.9
1.8
—
—
—
0
0
34
220
1.69
1.84
1.6
1.6
1305.96
1182.63
nmol/l
0.35
28
161
5
12
4.26
1.83
2.2
2.3
1.01
0.47
e9/l
—
5
12
64
484
1.53
1.83
4.2
3.4
2.36
2.36
mmol/l
0.09
59
448
27
164
1.77
1.82
1.9
1.9
—
—
—
0
0
48
342
1.57
1.78
2.9
2.0
—
—
—
0
0
149
1370
1.90
1.67
17.9
13.6
86.53
84.74
ml/min/173m2
0.44
141
1258
14
70
2.09
1.64
1.4
1.3
—
—
—
0
0
14
71
2.06
1.59
1.6
1.5
—
—
—
0
0
54
404
1.50
1.59
1.4
1.3
0.61
1.44
u/ml
1.27
22
112
154
1437
2.08
1.56
19.7
14.2
22.70
21.94
mg/l
0.11
136
1164
12
58
2.15
1.53
3.2
2.4
59.86
5210.26
u/l
—
7
19
9
38
2.45
1.48
2.6
2.3
—
—
—
0
0
7
29
2.47
1.41
1.3
2.8
4.63
9.60
pmol/l
—
7
29
6
23
2.67
1.38
1.2
1.1
—
—
—
0
0
24
155
1.64
1.32
4.9
4.3
194.42
236.52
u/l
4.13
24
150
54
419
1.43
1.29
4.7
4.0
1.74
10.12
mg/mmol
2.80
37
260
34
241
1.52
1.28
3.6
2.9
1.26
0.88
e6/l
0.15
19
114
5
19
2.68
1.22
1.8
1.2
—
—
—
0
0
142
1314
1.58
1.21
4.5
4.1
1.28
1.25
mmol/l
0.23
135
1227
7
31
2.31
1.12
2.4
1.5
—
—
—
0
0
10
52
1.98
1.08
1.5
1.4
—
—
—
0
0
10
52
1.98
1.08
2.0
1.2
—
—
—
0
0
10
53
1.94
1.03
2.2
1.9
—
—
—
0
0
12
69
1.80
0.99
3.1
3.2
1.99
1.50
mmol/l
0.17
12
53
9
50
1.85
0.98
2.1
1.8
—
—
—
0
0
21
142
1.55
0.98
6.4
7.9
4.80
5.08
kpa
0.87
21
137
39
300
1.39
0.97
1.5
1.3
20.91
26.47
iu/ml
—
10
98
9
51
1.81
0.96
1.7
1.1
—
7.10
—
0
8
112
1010
1.34
0.96
3.2
3.5
—
—
—
0
0
20
136
1.54
0.92
1.6
1.9
2.84
3.39
mmol/l
1.18
15
104
6
30
2.04
0.88
1.5
1.5
—
—
—
0
0
49
402
1.31
0.81
4.0
3.1
1.77
0.37
e6/l
0.47
36
281
25
185
1.41
0.78
2.2
2.1
3.35
3.29
ratio
0.08
19
155
60
511
1.27
0.74
2.6
3.0
29.04
31.38
u/l
0.32
55
483
69
599
1.26
0.73
2.3
2.0
104.06
97.84
pmol/l
0.49
41
317
7
40
1.78
0.72
1.7
1.2
—
—
—
0
0
19
136
1.45
0.70
2.5
2.1
—
—
—
0
0
17
119
1.48
0.70
2.5
1.9
—
—
—
0
0
13
87
1.54
0.65
8.0
7.0
24.36
24.66
mmol/l
0.10
13
87
138
1309
1.33
0.64
7.7
6.0
39.85
38.78
mmol/mol
0.68
133
1249
21
157
1.39
0.63
5.0
4.9
35.81
33.24
%
0.57
16
100
5
30
1.69
0.62
1.6
1.1
—
10.73
—
0
10
8
51
1.60
0.61
1.4
1.4
1.04
1.20
g/l
—
8
51
32
258
1.30
0.60
1.7
1.5
—
—
—
0
0
6
36
1.69
0.57
1.3
2.0
—
—
—
0
0
6
36
1.69
0.57
1.2
1.4
—
—
—
0
0
6
37
1.64
0.56
2.7
2.5
3.93
3.56
g/l
—
6
37
6
37
1.64
0.56
1.0
1.1
—
—
—
0
0
33
271
1.27
0.54
1.5
1.3
19.12
5.58
u/ml
0.62
18
105
6
40
1.52
0.52
1.5
1.5
—
—
—
0
0
33
273
1.26
0.51
4.8
4.6
20.87
23.14
%
0.49
19
116
7
47
1.51
0.48
1.3
1.5
—
—
—
0
0
7
49
1.45
0.46
1.6
1.4
0.21
0.23
g/l
—
7
49
40
343
1.22
0.46
2.0
1.7
—
—
—
0
0
27
223
1.25
0.43
4.6
3.2
0.32
2.84
e6/l
2.55
13
97
5
32
1.58
0.42
1.2
1.6
—
—
—
0
0
5
33
1.53
0.41
1.4
1.1
0.90
0.94
nmol/l
—
5
28
111
1050
1.17
0.40
4.1
3.2
38.29
45.69
u/l
0.76
102
1005
128
1229
1.19
0.36
20.1
18.2
13.50
13.52
%
0.08
122
1222
22
262
0.82
0.34
3.8
3.5
13.54
167.47
ng/l
1.53
13
186
25
213
1.20
0.31
3.2
2.8
0.61
0.76
ug/l
0.91
16
114
7
54
1.31
0.31
1.6
1.2
—
—
—
0
0
7
55
1.28
0.30
1.6
1.2
—
—
—
0
0
21
243
0.84
0.25
3.0
2.3
—
—
—
0
0
64
601
1.11
0.22
2.1
2.0
1.31
1.39
mmol/l
0.44
58
510
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
1.28
—
0
5
12
101
1.20
0.17
1.4
1.2
—
—
—
0
0
10
117
0.85
0.13
3.2
2.3
13.04
14.11
nmol/l
—
10
112
21
227
0.91
0.09
2.9
2.2
—
—
—
0
0
6
54
1.12
0.09
1.0
1.3
—
—
—
0
0
138
1363
1.08
0.09
5.7
4.7
5.99
5.84
mmol/l
0.55
128
1273
5
62
0.80
0.08
3.2
1.6
46.60
34.92
nmol/l
—
5
62
9
84
1.08
0.07
1.8
3.1
23.21
24.44
mmol/l
—
9
84
22
214
1.03
0.00
1.9
1.8
1.75
1.37
%
1.50
22
188
10
96
1.04
0.00
1.0
1.0
—
—
—
0
0
14
138
1.02
0.00
4.6
3.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
5
54
0.92
0.00
2.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.30
—
0
6
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
-0.00
0.0
3.2
—
106.80
—
0
5
5
49
1.02
-0.00
1.6
1.5
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.3
—
4.55
—
0
6
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.2
—
205.50
—
0
5
0
6
0.00
-0.00
0.0
3.3
—
10.47
—
0
6
0
6
0.00
-0.00
0.0
2.7
—
101.50
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_PELVIC_BONES_SACRUM_COCCYX – Benign neoplasm: Pelvic bones, sacrum and coccyx
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data